October Pharma achieves 88% profit increase

Updated 8/13/2020 10:45:00 AM

ArabFinance: October Pharma (OCPH) reported a net profit of EGP 27 million in the first half (H1) of 2020, according to the company’s August 16th financial statements filed to the Egyptian Exchange.

The figure marked a 88% Year on Year rise from EGP 3.33 million achieved in H1 2019.

The company distributed cash dividends of EGP 1.50 per share on July 29th to the shareholders recorded on July 26th.

October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations. The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.